[1]
“Combined Effects of ARNI & SGLT2 2 Inhibitors in Diabetic Patients with Heart Failure with Reduced Ejection Fraction”, IJBR, vol. 3, no. 4, pp. 265–270, Apr. 2025, doi: 10.70749/ijbr.v3i4.1025.